World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
421 Inhibrx, Inc. $196.9 M United States US Healthcare US Biotechnology
422 Newron Pharmaceuticals SpA $193.0 M Italy Italian Healthcare Italian Biotechnology
423 Spectrum Pharmaceuticals, Inc. $192.9 M

(July 1, 2023)

United States US Healthcare US Biotechnology
424 Vaccitech plc $192.7 M

(Jan. 1, 2024)

United Kingdom UK Healthcare UK Biotechnology
425 Savior Lifetec Corp $192.4 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
426 Merrimack Pharmaceuticals, Inc. $189.8 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
427 Inhibikase Therapeutics, Inc. $189.4 M United States US Healthcare US Biotechnology
428 Cybin, Inc. $188.3 M Canada Canadian Healthcare Canadian Biotechnology
429 ZIOPHARM Oncology, Inc. $187.1 M

(June 1, 2022)

United States US Healthcare US Biotechnology
430 LogicBio Therapeutics, Inc. $185.8 M United States US Healthcare US Biotechnology
431 Race Oncology Limited $181.6 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
432 Harpoon Therapeutics, Inc. $178.6 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
433 Vaxart, Inc. $178.6 M United States US Healthcare US Biotechnology
434 Veru Inc. $177.1 M United States US Healthcare US Biotechnology
435 INmune Bio, Inc. $174.7 M United States US Healthcare US Biotechnology
436 Malin Corp plc $173.5 M Ireland Irish Healthcare Irish Biotechnology
437 Molecular Partners AG $173.4 M Switzerland Swiss Healthcare Swiss Biotechnology
438 TOT BIOPHARM International Company Ltd $172.7 M China Chinese Healthcare Chinese Biotechnology
439 Genfit SA $172.4 M France French Healthcare French Biotechnology
440 Dimerix Limited $172.2 M

(July 1, 2024)

Australia Australian Healthcare Australian Biotechnology
441 ADC Therapeutics SA $170.2 M Switzerland Swiss Healthcare Swiss Biotechnology
442 Sinphar Pharmaceutical Co.,Ltd. $170.0 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
443 Alector, Inc. $169.4 M United States US Healthcare US Biotechnology
444 Egetis Therapeutics AB $168.9 M Sweden Swedish Healthcare Swedish Biotechnology
445 Ryvu Therapeutics SA $168.8 M Poland Polish Healthcare Polish Biotechnology
446 Berkeley Lights, Inc. $168.7 M

(Jan. 1, 2023)

United States US Healthcare US Biotechnology
447 Sorrento Therapeutics, Inc. $168.4 M

(April 1, 2023)

United States US Healthcare US Biotechnology
448 Greenwich LifeSciences, Inc. $167.6 M United States US Healthcare US Biotechnology
449 Sutro Biopharma, Inc. $167.4 M United States US Healthcare US Biotechnology
450 Lyell Immunopharma, Inc. $166.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2025

421. Inhibrx, Inc.

Company Profile: Inhibrx, Inc.
Market Cap (USD): $196.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

422. Newron Pharmaceuticals SpA

Company Profile: Newron Pharmaceuticals SpA
Market Cap (USD): $193.0 M
Country: Italy
Sector: Italian Healthcare
Industry: Italian Biotechnology

423. Spectrum Pharmaceuticals, Inc.

Company Profile: Spectrum Pharmaceuticals, Inc.
Market Cap (USD): $192.9 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

424. Vaccitech plc

Company Profile: Vaccitech plc
Market Cap (USD): $192.7 M (Jan. 1, 2024)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

425. Savior Lifetec Corp

Company Profile: Savior Lifetec Corp
Market Cap (USD): $192.4 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

426. Merrimack Pharmaceuticals, Inc.

Company Profile: Merrimack Pharmaceuticals, Inc.
Market Cap (USD): $189.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

427. Inhibikase Therapeutics, Inc.

Company Profile: Inhibikase Therapeutics, Inc.
Market Cap (USD): $189.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

428. Cybin, Inc.

Company Profile: Cybin, Inc.
Market Cap (USD): $188.3 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

429. ZIOPHARM Oncology, Inc.

Company Profile: ZIOPHARM Oncology, Inc.
Market Cap (USD): $187.1 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

430. LogicBio Therapeutics, Inc.

Company Profile: LogicBio Therapeutics, Inc.
Market Cap (USD): $185.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

431. Race Oncology Limited

Company Profile: Race Oncology Limited
Market Cap (USD): $181.6 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

432. Harpoon Therapeutics, Inc.

Company Profile: Harpoon Therapeutics, Inc.
Market Cap (USD): $178.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

433. Vaxart, Inc.

Company Profile: Vaxart, Inc.
Market Cap (USD): $178.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

434. Veru Inc.

Company Profile: Veru Inc.
Market Cap (USD): $177.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

435. INmune Bio, Inc.

Company Profile: INmune Bio, Inc.
Market Cap (USD): $174.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

436. Malin Corp plc

Company Profile: Malin Corp plc
Market Cap (USD): $173.5 M
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

437. Molecular Partners AG

Company Profile: Molecular Partners AG
Market Cap (USD): $173.4 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

438. TOT BIOPHARM International Company Ltd

Company Profile: TOT BIOPHARM International Company Ltd
Market Cap (USD): $172.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

439. Genfit SA

Company Profile: Genfit SA
Market Cap (USD): $172.4 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

440. Dimerix Limited

Company Profile: Dimerix Limited
Market Cap (USD): $172.2 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

441. ADC Therapeutics SA

Company Profile: ADC Therapeutics SA
Market Cap (USD): $170.2 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

442. Sinphar Pharmaceutical Co.,Ltd.

Company Profile: Sinphar Pharmaceutical Co.,Ltd.
Market Cap (USD): $170.0 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

443. Alector, Inc.

Company Profile: Alector, Inc.
Market Cap (USD): $169.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

444. Egetis Therapeutics AB

Company Profile: Egetis Therapeutics AB
Market Cap (USD): $168.9 M
Country: Sweden
Sector: Swedish Healthcare
Industry: Swedish Biotechnology

445. Ryvu Therapeutics SA

Company Profile: Ryvu Therapeutics SA
Market Cap (USD): $168.8 M
Country: Poland
Sector: Polish Healthcare
Industry: Polish Biotechnology

446. Berkeley Lights, Inc.

Company Profile: Berkeley Lights, Inc.
Market Cap (USD): $168.7 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

447. Sorrento Therapeutics, Inc.

Company Profile: Sorrento Therapeutics, Inc.
Market Cap (USD): $168.4 M (April 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

448. Greenwich LifeSciences, Inc.

Company Profile: Greenwich LifeSciences, Inc.
Market Cap (USD): $167.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

449. Sutro Biopharma, Inc.

Company Profile: Sutro Biopharma, Inc.
Market Cap (USD): $167.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

450. Lyell Immunopharma, Inc.

Company Profile: Lyell Immunopharma, Inc.
Market Cap (USD): $166.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology